Key result
Low-dose temocapril prevents renal lesions via c-myc suppression without lowering blood pressure in hypertensive rats.
Why the study?
Does temocapril prevent renal lesions in a hypertensive rat model of chronic focal and segmental glomerulosclerosis?
Does temocapril prevent renal lesions in a hypertensive rat model of chronic focal and segmental glomerulosclerosis?
Temocapril prevents renal damage in a hypertensive rat model of glomerulosclerosis independent of its blood pressure-lowering effects.
Answers are grounded in this paper and cite their sources.
May suggest BP-independent renoprotection by low-dose ACEIs in rat FGS; leaves open translation to human CKD and requires clinical trials.
To investigate how the interruption of the renin-angiotensin system (RAS) and reduction of blood pressure (BP) affect the lesions of chronic focal and segmental glomerulosclerosis (FGS), we studied the effects of high and low doses of angiotensin-converting enzyme inhibitors (temocapril - TEM) a newly developed ACE inhibitor with biliary tract excretion, on the hypertensive model of FGS. A high dose of TEM significantly lowered BP and suppressed both intense proteinuria and glomerular extracapillary lesions including macrophage infiltration. On the other hand, although a low dose of TEM did not significantly lower BP throughout the experimental period, it prevented renal lesions almost in the same manner as high-dose TEM with suppression of c-myc gene expression in glomeruli. These findings suggest that in PAN-induced chronic FGS, the systemic BP elevation could not be the major factor for the progression of renal damage which TEM could prevent without significant lowering of BP.
No takes yet. Share an insight, caveat, or question.
Suyama et al. (2000) studied Hypertensive model of focal and segmental glomerulosclerosis (FGS). Temocapril was evaluated on Blood pressure, proteinuria, and glomerular extracapillary lesions. Low-dose temocapril prevented renal lesions and suppressed c-myc gene expression in glomeruli without significantly lowering blood pressure in a hypertensive rat model of FGS.
Synapse has enriched 10 related papers. Consider them for comparative context: